Search results for "Cognition disorders"

showing 10 items of 277 documents

Monitoring cognitive changes: Psychometric properties of six cognitive tests

2004

Objectives. Repeated neuropsychological assessments are often used to monitor change in cognitive functioning over time. Thus, knowledge about the reliability and stability of neuropsychological tests and the effects of age and IQ is of paramount importance. In this study we document, for six cognitive tests: test-retest reliabilities, practice effects, reliable change (RC) indices corrected for practice, and the impact of premorbid IQ and age. Design. A sample of 188 normal adults (aged 40-70 years) were administered, on two occasions, one or more of the following tests: the Graded Naming Test (GNT), the Silhouettes Test, two tests of verbal fluency, the Modified Wisconsin Card Sorting Tes…

AdultMalemedicine.medical_specialtyPsychometricsBRAIN-INJURYTest validityNeuropsychological TestsAudiologyNAMING TESTNational Adult Reading TestSeverity of Illness IndexMEMORY TESTDevelopmental psychologyDEMOGRAPHIC-VARIABLESTEST-PERFORMANCEmedicineHumansLONGITUDINAL PROFILESAchievement testVerbal fluency testAgedCARD SORTING TESTSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaIntelligence quotientmedicine.diagnostic_testReproducibility of ResultsGeneral MedicineNeuropsychological testMiddle AgedCognitive testTest (assessment)ALZHEIMERS-DISEASEVERBAL FLUENCYClinical PsychologyPractice PsychologicalFemaleTEST-RETEST RELIABILITYCognition DisordersPsychologyGraded Naming Test Silhouettes Test Verbal fluency tests Modified Wisconsin Card Sorting Test New Symbol Digit Test National Adult Reading Test (NART)
researchProduct

Are negative mood states associated with cognitive function in newly diagnosed patients with epilepsy?

2000

Summary: Purpose: The association of self-reported subclinical depressive symptoms and negative mood states with cognitive functioning was evaluated in 51 consecutive newly diagnosed adult persons with epilepsy. Methods: Emotional state was assessed with Profile of Mood States (POMS) and Brief Depression Scale (BDS) and was correlated with a battery of neuropsychological tests. Results: Patients with epilepsy reported more depressive symptoms in BDS than in controls. They also had more feeling of bewilderment and less vigor on POMS. Higher scores in BDS and in POMS inefficiency scale were associated with slower nondominant hand tapping, but emotional state did not correlate with cognitive m…

AdultMalemedicine.medical_specialtyPsychometricsPersonality InventoryComorbidityNeuropsychological TestsProfile of mood states050105 experimental psychology03 medical and health sciencesEpilepsy0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesPsychiatryDepression (differential diagnoses)FinlandPsychiatric Status Rating ScalesDepressive DisorderEpilepsyMood Disorders05 social sciencesNeuropsychologyCognitionmedicine.diseaseComorbidityNeurologyFemaleNeurology (clinical)Personality Assessment InventoryPsychologyCognition DisordersAttitude to Health030217 neurology & neurosurgeryPsychomotor PerformanceEpilepsia
researchProduct

Neurocognitive Impairment in Bipolar Patients With and Without History of Psychosis

2008

Objective: Little is known regarding the impact of psychotic symptoms on the cognitive functioning of bipolar patients. Findings from previous reports are controversial and mainly focused on current psychotic symptoms. The main aim of this study was to ascertain whether the history of psychotic symptoms was associated with greater cognitive impairment in euthymic bipolar patients. Method: Sixty-five euthymic bipolar disorder patients (DSM-IV criteria; 35 with a history of psychotic symptoms and 30 without such a history) were assessed through a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions. Thirty-five healthy controls were also in…

AdultMalemedicine.medical_specialtyPsychosisBipolar DisorderNeuropsychological TestsMemorymedicineHumansAttentionMedical historyBipolar disorderMedical History TakingPsychiatryMemory DisordersCognitive disorderNeuropsychologyMiddle AgedVerbal Learningmedicine.diseaseExecutive functionsPsychiatry and Mental healthPsychotic DisordersResearch DesignCase-Control StudiesFemaleVerbal memoryCognition DisordersPsychologyNeurocognitiveClinical psychologyThe Journal of Clinical Psychiatry
researchProduct

Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cogn…

2011

Cognitive impairment in schizophrenia and psychosis is ubiquitous and acknowledged as a core feature of clinical expression, pathophysiology, and prediction of functioning. However, assessment of cognitive functioning is excessively time-consuming in routine practice, and brief cognitive instruments specific to psychosis would be of value. Two screening tools have recently been created to address this issue, i.e., the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). The aim of this research was to examine the comparative validity of these two brief instruments in relation to a global cognitive score. 161 patients with p…

AdultMalemedicine.medical_specialtyPsychosisBipolar DisorderPsychometricsConcurrent validityNeuropsychological TestsPsychological researchSeverity of Illness IndexExecutive FunctionMemorymedicineHumansManic-depressive illnessAttentionBipolar disorderNeuropsychological assessmentPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesTrastorn bipolarmedicine.diagnostic_testReproducibility of ResultsCognitionMiddle Agedmedicine.diseaseCognitivismePsychiatry and Mental healthROC CurveSchizophreniaCognitive remediation therapyArea Under CurveInvestigació psicològicaSchizophreniaFemaleSchizophrenic PsychologyEsquizofrèniaCognition DisordersPsychologyCognitivismClinical psychologyBrief Cognitive Assessment Tool
researchProduct

Course of cognitive deficits in first episode of non-affective psychosis: a 3-year follow-up study.

2013

Abstract Cognitive dysfunctions are critical determinants of the quality of life and functionality in schizophrenia. Whether the cognitive deficits present at an early stage, are static or change across one's lifespan is still under debate. This study aims to investigate the long-term (3 years) course of cognitive deficits in a large and representative cohort of first episode schizophrenia spectrum patients (N = 155),and evaluate their influence on disability. In addition, a healthy control sample (N = 43) was also studied for comparison. This study evaluates the performance of patients and controls in a battery of cognitive assessments using baseline, 1-year and 3-year follow-up designs. T…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentNeuropsychological TestsCohort StudiesYoung AdultVisual memorymedicineHumansSpectrum disorderEffects of sleep deprivation on cognitive performanceCognitive declinePsychiatryEpisodic memoryBiological PsychiatryAgedFirst episodePsychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle AgedVerbal Learningmedicine.diseasePsychiatry and Mental healthSchizophreniaDisease ProgressionSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersClinical psychologySchizophrenia research
researchProduct

Cognitive functioning and anhedonia in subjects at risk for schizophrenia

1993

This study investigated the performance of individuals with familiar loading of schizophrenia (healthy siblings of schizophrenic inpatients) on three neuropsychological tasks assumed to require frontal lobe functions: Trail Making Test (TMT), verbal fluency and Wisconsin Card Sorting Test (WCST). Healthy siblings of schizophrenics differed in performance from healthy controls not only on the WCST, but also on the Trail Making Test and the verbal fluency task. Furthermore, scores of physical anhedonia, assessed in a self-report rating scale (Chapman et al., 1976) were also significantly higher in the high risk group than in the control sample. However, healthy siblings of schizophrenics did …

AdultMalemedicine.medical_specialtyTrail Making TestNeuropsychological Testsbehavioral disciplines and activitiesSchizotypal Personality DisorderWisconsin Card Sorting TestRisk FactorsSchizophrenic PsychologymedicineHumansVerbal fluency testAttentionAffective SymptomsPsychiatryBiological PsychiatryPsychiatric Status Rating Scalesmedicine.diagnostic_testNeuropsychologyAnhedoniaNeuropsychological testmedicine.diseaseFrontal LobePsychiatry and Mental healthSchizophreniaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomCognition DisordersPsychologyClinical psychologySchizophrenia Research
researchProduct

Comparative neurocognitive effects of lithium and anticonvulsants in long-term stable bipolar patients

2015

Background: The aim of choosing a mood-stabilizing drug (lithium or anticonvulsants) or a combination of them with minimal neurocognitive effects is to stimulate the development of criteria for a therapeutic adequacy, particularly in Bipolar Disorder (BD) patients who are clinically stabilized. Method: Three groups of BD patients were established according to their treatment: (i) lithium monotherapy (n=29); (ii) lithium together with one or more anticonvulsants (n=28); and (iii) one or more anticonvulsants (n=16). A group of healthy controls served as the control (n=25). The following tests were applied: Wechsler Adult Intelligence Scale, Trail Making Test, Wechsler Memory Scale, Rey Comple…

AdultMalemedicine.medical_specialtyWechsler Memory ScaleBipolar DisorderTrail Making TestNeuropsychological TestsAudiologyExecutive FunctionYoung Adult03 medical and health sciences0302 clinical medicineVisual memoryWisconsin Card Sorting TestAntimanic AgentsmedicineHumansAttentionWorking memoryWechsler Adult Intelligence ScaleMiddle AgedExecutive functions030227 psychiatryPsychiatry and Mental healthClinical PsychologyMemory Short-TermLithium CompoundsAnticonvulsantsDrug Therapy CombinationFemaleCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryClinical psychologyJournal of Affective Disorders
researchProduct

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

2014

Abstract Objective Facial affect recognition, a basic building block of social cognition, is often impaired in schizophrenia. Poor facial affect recognition is closely related to poor functional outcome; however, neither social cognitive impairments nor functional outcome are sufficiently improved by antipsychotic drug treatment alone. Adjunctive repetitive transcranial magnetic stimulation (rTMS) has been shown to enhance cognitive functioning in both healthy individuals and in people with neuropsychiatric disorders and to ameliorate clinical symptoms in psychiatric disorders, but its effects on social cognitive impairments in schizophrenia have not yet been studied. Therefore, we evaluate…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentBiophysicsPrefrontal CortexStimulationAudiologylcsh:RC321-571Young AdultCognitionDouble-Blind MethodSocial cognitionRepetitive transcranial magnetic stimulation (rTMS)medicineHumansIn patientCognitive skillPsychiatrylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryFacial affectGeneral NeuroscienceMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationFacial affect recognitionTranscranial magnetic stimulationFacial ExpressionAffectSchizophreniaSchizophreniaChronic schizophreniaFemaleSchizophrenic PsychologyNeurology (clinical)PsychologyCognition DisordersBrain Stimulation
researchProduct

Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives

2010

"Cognitive impairment has been recognized since the earliest descriptions of schizophrenia as a core feature of the illness and different programmes have been developed to remediate these deficits. In all likelihood it is important for compliance and adherence to treatment that not only the patients but also their relatives be aware of the patients; cognitive deficits. Sixty-two patients with a diagnosis of schizophrenia and, for each one of them, one family member and an informant from the medical staff, were recruited and administered the Schizophrenia Cognition Rating Scale (SCoRS) ratings. Patients were tested for cognitive deficits with a neuropsychological battery and their performanc…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentNeuropsychological TestsExecutive FunctionmedicineHumansFamilyCognitive skillFirst-degree relativesPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesRehabilitationCognitionAwarenessmedicine.diseaseExecutive functionsPsychiatry and Mental healthCognitive remediation therapySchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersDiagnosis of schizophreniaClinical psychology
researchProduct

Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis

2011

Objectives: To identify associations between cognitive impairment and imaging measures in a cross-sectional study of patients with primary progressive multiple sclerosis (PPMS). Methods: Neuropsychological tests were administered to 27 patients with PPMS and 31 controls. Patients underwent brain conventional magnetic resonance imaging (MRI) sequences, volumetric scans and magnetization transfer (MT) imaging; MT ratio (MTR) parameters, grey matter (GM) and normal-appearing white matter (NAWM) volumes, and WM T2 lesion load (T2LL) were obtained. In patients, multiple linear regression models identified the imaging measure associated with the abnormal cognitive tests independently from the ot…

AdultMalemedicine.medical_specialtyprimary progressive multiple sclerosisAudiologyGrey matterNeuropsychological TestsWhite matterExecutive FunctionCognitionMemoryPredictive Value of TestsLondonmedicineHumansAttentionEffects of sleep deprivation on cognitive performanceAgedChi-Square Distributionmedicine.diagnostic_testSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaVerbal BehaviorMultiple sclerosisNeuropsychologyBrainCognitionMagnetic resonance imagingMiddle AgedMultiple Sclerosis Chronic Progressivemedicine.diseaseMagnetic Resonance ImagingCognitive testmedicine.anatomical_structureCross-Sectional StudiesNeurologyCase-Control StudiesLinear ModelsFemaleNeurology (clinical)PsychologyCognition DisordersNeuroscience
researchProduct